Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Pomalidomide Plus Low Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World 'Powerful' Study

Blood (2020) 136 (Supplement 1): 33–35.

https://doi.org/10.1182/blood-2020-138390

Published: 2020

Journal Articles

Efficacy of Daratumumab Monotherapy on Bone Metabolism of Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results from the Phase 2 Rebuild Study

Evangelos Terpos, MDPhD, Efstathios Kastritis, MD, Evdoxia Hatjiharissi, MD, Eirini Katodritou, MD, Evangelos Eleutherakis-Papaiakovou, MD, Evgenia Verrou, MD, Maria Gavriatopoulou, Alexandros Leonidakis, PhD, Ioannis Ntanasis-Stathopoulos, MD, Sosana Delimpasi, MD, Marie-Christine Kyrtsonis, MD, Maria Papaioannou, MD, Argiris Symeonidis, MD PhD, Meletios A Dimopoulos

Blood (2020) 136 (Supplement 1): 29.

https://doi.org/10.1182/blood-2020-140261

Published: 2020

Journal Articles

T Cell Immunoprofiling of Patients with Relapsed and/or Refractory Myeloma Who Receive Daratumumab Monotherapy: Longitudinal Analysis during 7 Cycle Follow-up of the Rebuild Phase 2 Study

Elisavet Vlachonikola, PhD, Efstathios Kastritis, MD, Evdoxia Hatjiharissi, MD, Eirini Katodritou, MD, Alexandra Siorenta, MD, Electra Sofou, Marina Gerousi, Konstantia Kotta, Maria Karipidou, Maria Gavriatopoulou, Sosana Delimpasi, MD, Argiris Symeonidis, MD PhD, Kostas Stamatopoulos, MD, Meletios A Dimopoulos, Evangelos Terpos, MDPhD, Anastasia Chatzidimitriou

Blood (2020) 136 (Supplement 1): 28.

https://doi.org/10.1182/blood-2020-139236

Published: 2020

Journal Articles

Daratumumab with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Severe Renal Impairment: Results on Efficacy and Safety of the Phase 2 Dare Study

Efstathios Kastritis, MD, Evangelos Terpos, MDPhD, Argiris Symeonidis, MD PhD, Sosana Delimpasi, MD, Michele Cavo, Elena Zamagni, Eirini Katodritou, MD, Elena Rivolti, MD, Marie-Christine Kyrtsonis, MD, Maria Gavriatopoulou, Maria Roussou, MD, Despina Fotiou, MD, Evdoxia Hatjiharissi, MD, Nikolaos Kanellias, MD, Magdalini Migkou, Meletios A Dimopoulos

Blood (2020) 136 (Supplement 1): 48–49.

https://doi.org/10.1182/blood-2020-140322

Published: 2020

Journal Articles

Efficacy and Tolerability of Daratumumab with Ixazomib and Dexamethasone in Patients with One Prior Lenalidomide-Based Regimen: Preliminary Results of the Phase 2 Daria Study

Evangelos Terpos, MDPhD, Maria Gavriatopoulou, Eirini Katodritou, MD, Evdoxia Hatjiharissi, MD, Ioanna Dialoupi, MD, Evgenia Verrou, MD, Alexandros Leonidakis, PhD, Magdalini Migkou, Sosana Delimpasi, MD, Argiris Symeonidis, MD PhD, Efstathios Kastritis, MD, Meletios A Dimopoulos

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-140301

Published: 2020

Journal Articles

Second Primary Malignancies and Disease Transformation in Newly Diagnosed Symptomatic Patients with Waldenstrom's Macroglobulinemia: An Analysis from the Greek Myeloma Study Group

Blood (2018) 132 (Supplement 1): 1978.

https://doi.org/10.1182/blood-2018-99-115725

Published: 2018

Journal Articles

Involvement of Fatty Acid Synthase in Azacytidine-Induced Cytotoxicity in Waldenstrom's Macroglobulinemia.

Lian Xu, Christopher J Patterson, Jenny Sun, MD, Guang Yang, PhD, Yangsheng Zhou, MD, PhD, Zachary Hunter, Evdoxia Hatjiharissi, MD, Bryan Ciccarelli, Ping Gong, Xia Liu, Hsiuyi Tseng, Thea Ioakimidis, MS, Robert Manning, Christina Hanzis, Yang Cao, Megan Lewicki, Steven Treon, MD, PhD

Blood (2009) 114 (22): 3731.

https://doi.org/10.1182/blood.V114.22.3731.3731

Published: 2009

Journal Articles

Gene Expression Profiling Distinguishes Waldenstrom's Macroglobulinemia Patients Presenting with Familial Disease, Advanced IPSS Prognostic Score, and Previous Treatment with Rituximab.

Zachary Hunter, Evdoxia Hatjiharissi, MD, Jenny Sun, MD, Yang Cao, Hsiuyi Tseng, Megan Lewicki, Lian Xu, Guang Yang, PhD, Yangsheng Zhou, MD, PhD, Xia Liu, Ping Gong, Christina Hanzis, Thea Ioakimidis, MS, Christopher J Patterson, Patricia Sheehy, NP, Bart Barlogie, MD, PhD, John D Shaughnessy, Jr, PhD, Steven Treon, MD, PhD

Blood (2009) 114 (22): 3930.

https://doi.org/10.1182/blood.V114.22.3930.3930

Published: 2009

Journal Articles

Histone Deacetylase Inhibitors Demonstrate Significant Preclinical Activity as Single Agents, and in Combination with Bortezomib in Waldenstrom's Macroglobulinemia.

Blood (2009) 114 (22): 4785.

https://doi.org/10.1182/blood.V114.22.4785.4785

Published: 2009

Journal Articles

Aberrant DNA Methylation and Transcriptional Silencing of DLC-1 in Waldenstrom's Macroglobulinemia.

Lian Xu, Bryan Ciccarelli, Evdoxia Hatjiharissi, MD, Guang Yang, PhD, Yangsheng Zhou, MD, PhD, Zachary Hunter, Jenny Sun, MD, Ping Gong, Xia Liu, Hsiuyi Tseng, Thea Ioakimidis, MS, Robert Manning, Christina Hanzis, Yang Cao, Megan Lewicki, Christopher J Patterson, Steven Treon, MD, PhD

Blood (2009) 114 (22): 2954.

https://doi.org/10.1182/blood.V114.22.2954.2954

Published: 2009

Journal Articles

Proteomic Analysis of Multiple Myeloma Identifies Upregulation of CRIK Protein, a Novel Protein Regulating Migration and Adhesion

Hai T. Ngo, Evdoxia Hatjiharissi, MD, Alexey A. Leontovich, PhD, Wee Chng, PhD, Mena Farag, Xavier Leleu, MD, PhD, Xiaoying Jia, Judith Runnels, PhD, Aldo Roccaro, MD, PhD, Abdel Kareem Azab, PhD, Feda Azab, Antonio Sacco, Nicholas Burwick, MD, Molly R. Melhem, Kenneth C. Anderson, MD, Rafael Fonseca, MD, Thomas E. Witzig, MD, Irene M. Ghobrial, MD

Blood (2008) 112 (11): 643.

https://doi.org/10.1182/blood.V112.11.643.643

Published: 2008

Journal Articles

Imatinib Mesylate (Gleevec®) Produces Responses in Patients with Relapsed/Refractory Waldenstrom’s Macroglobulinemia.

Jacob D. Soumerai, Kelly E. O’Connor, Leukothea M. Ioakimidis, MS, Christopher J. Patterson, Bryan T. Ciccarelli, Renee Leduc, Zachary R. Hunter, Marybeth Nelson, PA-C, Aldo M. Roccaro, MD, Xavier Leleu, MD, Evdoxia Hatjiharissi, MD, Sophia Adamia, PhD, Lian Xu, Irene M. Ghobrial, MD, Steven P. Treon, MD, PhD

Blood (2007) 110 (11): 2575.

https://doi.org/10.1182/blood.V110.11.2575.2575

Published: 2007

Journal Articles

Targeting NF-kB by Perifosine, Bortezomib and Rituximab in Waldenstrom Macroglobulinemia (WM).

Xavier Leleu, MD, Eeckhoute Jerome, PhD, Xiaoying Jia, Anne-Sophie Moreau, MD, Aldo M. Roccaro, MD, Mena Farag, Antonio Sacco, Evdoxia Hatjiharissi, MD, Hai T. Ngo, Judith Runnels, PhD, Abdelkareem Azab, PhD, Feda Azab, Zachary Hunter, Peter Sportelli, Steven P. Treon, MD, Teru Hideshima, MD, Kenneth C. Anderson, MD, Irene M. Ghobrial, MD

Blood (2007) 110 (11): 2512.

https://doi.org/10.1182/blood.V110.11.2512.2512

Published: 2007

Journal Articles

The Combination of Bortezomib and NPI-0052 Exerts Anti-Tumor Activity in Waldenstrom Macroglobulinemia (WM).

Aldo Roccaro, MD, Xavier Leleu, MD, Antonio Sacco, Xiaoying Jia, Anne-Sophie Moreau, MD, Hai Ngo, Abdelkareem Azab, Feda Azab, Evdoxia Hatjiharissi, MD, Steven Treon, MD, Teru Hideshima, MD, Michael Palladino, Kenneth Anderson, MD, Dharminder Chuahan, Irene Ghobrial, MD

Blood (2007) 110 (11): 1516.

https://doi.org/10.1182/blood.V110.11.1516.1516

Published: 2007

Journal Articles

Serum Immunoglobulin Free Light Chain (sFLC) Is a Sensitive Marker of Response in Waldenstrom Macroglobulinemia (WM).

Xavier Leleu, MD, Evdoxia Hatjiharissi, MD, Aldo M. Roccaro, MD, Anne-Sophie Moreau, MD, Renee Leduc, Marybeth Nelson, Mena Farag, Steven P. Treon, MD, Irene M. Ghobrial, MD

Blood (2007) 110 (11): 1486.

https://doi.org/10.1182/blood.V110.11.1486.1486

Published: 2007

Journal Articles

Comprehensive Molecular Characterization of Malignant and Microenvironmental Cells in Waldenstrom’s Macroglobulinemia by Gene Expression Profiling.

Evdoxia Hatjiharissi, MD, Constantine S. Mitsiades, MD,Ph.D, Ciccarelli T. Bryan, Xu Lian, Cao Yang, Sophia Adamia, Ph.D, Xavier Leleu, MD, Aldo Roccaro, MD, Leukothea Ioakimidis, Zachary R. Hunter, Christopher J. Patterson, Irene Ghobrial, MD, Steven P. Treon, MD,Ph.D

Blood (2007) 110 (11): 3174.

https://doi.org/10.1182/blood.V110.11.3174.3174

Published: 2007

Journal Articles

Resveratrol Exerts Antiproliferative Effect and Induces Apoptosis in Waldenstrom’s Macroglobulinemia.

Aldo Roccaro, MD, Xavier Leleu, MD, Anne-Sophie Moreau, MD, Antonio Sacco, Lian Xu, Evdoxia Hatjiharissi, MD, Bryan Ciccarelli, Christopher Patterson, Sophia Adamia, Domenico Russo, MD, Angelo Vacca, MD, Franco Dammacco, MD, Kenneth Anderson, MD, Irene Ghobrial, MD, Steven Treon, MD

Blood (2007) 110 (11): 1383.

https://doi.org/10.1182/blood.V110.11.1383.1383

Published: 2007

Journal Articles

Biological Sequelae of TRAF2 Downregulation in Waldenstrom Macroglobulinemia Cells.

Xavier Leleu, MD, Lian Xu, Zachary R. Hunter, Sophia Adamia, PhD, Evdoxia Hatjiharissi, MD, Anne-Sophie Moreau, MD, Aldo Roccaro, MD, Antonio Sacco, MD, Brian Ciccarelli, Robert J. Manning, Christopher J. Patterson, Irene M. Ghobrial, MD, Steven P. Treon, MD

Blood (2007) 110 (11): 3526.

https://doi.org/10.1182/blood.V110.11.3526.3526

Published: 2007

Journal Articles

A Novel Real-Time In Vivo Homing Model of Multiple Myeloma.

Judith M. Runnels, PhD, Costas Pitsillides, PhD, Joel A. Spencer, Joji Fujisaki, PhD, Hai Ngo, Evdoxia Hatjiharissi, MD, Xavier Leleu, MD, Anne-Sophie Moreau, MD, Xiaoying Jia, Teru Hideshima, MD, Nikhil Munshi, MD, Kenneth C. Anderson, PhD, Charles P. Lin, PhD, Irene M. Ghobrial, MD

Blood (2006) 108 (11): 242.

https://doi.org/10.1182/blood.V108.11.242.242

Published: 2006

Journal Articles

Abnormal Expression of TRAF Adapter Proteins in Waldenstrom’s Macroglobulinemia.

Xavier Leleu, MD, Lian Xu, Zachary R. Hunter, Anne-Sophie Moreau, MD, Xiaoying Jia, Garrett O’Sullivan, Vinod Bakthavachalam, Allen W. Ho, Evdoxia Hatjiharissi, MD, Hai T. N’Go, Daniel D. Santos, MD, Kelly O’Connor, Robert Manning, Jacob Soumerai, Christopher Patterson, Irene M. Ghobrial, MD, Steven P. Treon, MD

Blood (2006) 108 (11): 4640.

https://doi.org/10.1182/blood.V108.11.4640.4640

Published: 2006

NARROW

Pomalidomide Plus Low Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World 'Powerful' Study

Efficacy of Daratumumab Monotherapy on Bone Metabolism of Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results from the Phase 2 Rebuild Study

T Cell Immunoprofiling of Patients with Relapsed and/or Refractory Myeloma Who Receive Daratumumab Monotherapy: Longitudinal Analysis during 7 Cycle Follow-up of the Rebuild Phase 2 Study

Daratumumab with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Severe Renal Impairment: Results on Efficacy and Safety of the Phase 2 Dare Study

Efficacy and Tolerability of Daratumumab with Ixazomib and Dexamethasone in Patients with One Prior Lenalidomide-Based Regimen: Preliminary Results of the Phase 2 Daria Study

Second Primary Malignancies and Disease Transformation in Newly Diagnosed Symptomatic Patients with Waldenstrom's Macroglobulinemia: An Analysis from the Greek Myeloma Study Group

Involvement of Fatty Acid Synthase in Azacytidine-Induced Cytotoxicity in Waldenstrom's Macroglobulinemia.

Gene Expression Profiling Distinguishes Waldenstrom's Macroglobulinemia Patients Presenting with Familial Disease, Advanced IPSS Prognostic Score, and Previous Treatment with Rituximab.

Histone Deacetylase Inhibitors Demonstrate Significant Preclinical Activity as Single Agents, and in Combination with Bortezomib in Waldenstrom's Macroglobulinemia.

Aberrant DNA Methylation and Transcriptional Silencing of DLC-1 in Waldenstrom's Macroglobulinemia.

Proteomic Analysis of Multiple Myeloma Identifies Upregulation of CRIK Protein, a Novel Protein Regulating Migration and Adhesion

Imatinib Mesylate (Gleevec®) Produces Responses in Patients with Relapsed/Refractory Waldenstrom’s Macroglobulinemia.

Targeting NF-kB by Perifosine, Bortezomib and Rituximab in Waldenstrom Macroglobulinemia (WM).

The Combination of Bortezomib and NPI-0052 Exerts Anti-Tumor Activity in Waldenstrom Macroglobulinemia (WM).

Serum Immunoglobulin Free Light Chain (sFLC) Is a Sensitive Marker of Response in Waldenstrom Macroglobulinemia (WM).

Comprehensive Molecular Characterization of Malignant and Microenvironmental Cells in Waldenstrom’s Macroglobulinemia by Gene Expression Profiling.

Resveratrol Exerts Antiproliferative Effect and Induces Apoptosis in Waldenstrom’s Macroglobulinemia.

Biological Sequelae of TRAF2 Downregulation in Waldenstrom Macroglobulinemia Cells.

A Novel Real-Time In Vivo Homing Model of Multiple Myeloma.

Abnormal Expression of TRAF Adapter Proteins in Waldenstrom’s Macroglobulinemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only